IDEXX LABORATORIES INC (IX1.DE) Stock Income Statement
Europe - Frankfurt Stock Exchange - FRA:IX1 - US45168D1046 - Common Stock
612.6 EUR
+30.2 (+5.19%)
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.84B | 3.66B | 3.37B | 3.22B | 2.71B | |||
| Minority Interest Expense | N/A | 0.00 | 0.00 | 0.00 | -400.00K | |||
| Cost Of Goods | 1.51B | 1.47B | 1.36B | 1.33B | 1.14B | |||
| Gross Profit | 2.33B | 2.19B | 2.00B | 1.89B | 1.57B | |||
| Operating Expenses | 1.22B | 1.09B | 1.10B | 955.30M | 875.90M | |||
| Research and Development | 213.88M | 190.95M | 254.80M | 161.00M | 141.20M | |||
| Selling, General, and Administrative Expenses | 1.01B | 900.79M | 847.40M | 794.30M | 734.70M | |||
| Operating Income | 1.11B | 1.10B | 902.20M | 934.10M | 695.10M | |||
| Interest Income/Expense | -18.84M | -37.05M | -42.20M | -31.50M | -33.10M | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 1.09B | 1.06B | 860.00M | 902.70M | 662.00M | |||
| Income Tax | 226.87M | 216.13M | 180.90M | 157.80M | 79.90M | |||
| Net Income | 866.24M | 845.04M | 679.10M | 744.80M | 581.80M | |||
| EBITDA | 1.24B | 1.21B | 1.01B | 1.04B | 791.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 10.36 | 10.06 | 8.03 | 8.60 | 6.71 | |||
| Non GAAP EPS | 10.95 | 10.07 | 8.03 | 8.61 | 6.71 | |||
| Statistics | ||||||||
| Gross Profit Margin | 60.72% | 59.82% | 59.52% | 58.76% | 58.04% | |||
| Profit Margin | 22.53% | 23.08% | 20.17% | 23.16% | 21.49% | |||
| Operating Profit Margin | 28.92% | 30.00% | 26.79% | 29.05% | 25.68% | |||
All data in USD